The contributions of prevention and treatment to the decline in cardiovascular mortality: Lessons from a forty-year debate

Health Affairs

Volumn 31, Issue 10, 2012, Pages 2250-2258

  Jones, David S ^a   Greene, Jeremy A ^b  

^a HARVARD UNIVERSITY   (United States)

^b University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; DEFIBRILLATOR; FAT INTAKE; HEALTH CARE POLICY; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MORTALITY; PRIMARY PREVENTION; SECONDARY PREVENTION; SMOKING; SOCIAL STATUS; UNITED STATES;

CARDIOVASCULAR DISEASES; HUMANS; MODELS, THEORETICAL; MORTALITY; UNITED STATES;

EID: 84871331526     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0639     Document Type: Article

References (45)

1. Heron MP, Hoyert DL, Murphy SL, Xu JQ, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Hyattsville (MD): National Center for Health Statistics; 2009.
2. Moriyama I, Krueger DE, Stamler J. Cardiovascular diseases in the United States. Cambridge (MA): Harvard University Press; 1971.
3. Borhani NO, Hechter HH. Recent changes in CVR disease mortality in California. Public Health Rep. 1964; 79:147-60.
4. Moser RH. Editorial: signs of spring? JAMA. 1974;227(9):1049.
5. Walker WJ. Coronary mortality: what is going on? JAMA. 1974;227(9): 1045-6.
6. Gordon T, Thom T. The recent decrease in CHD mortality. Prev Med. 1975;4(2):115-25.
7. Stallones RA. The rise and fall of ischemic heart disease. Sci Am. 1980;243(5):53-9.
8. Levy RI. Declining mortality in coronary heart disease. Arteriosclerosis. 1981;1(5):312-25.
9. Havlik R, Feinleib M, eds. Proceedings of the Conference on the Decline in Coronary Heart Disease Mortality. Bethesda (MD): Department of Health, Education, and Welfare; 1979.
10. Stern MP. The recent decline in ischemic heart disease mortality. Ann of Intern Med. 1979;91(4):630-40.
11. Colgrove J. The McKeown thesis: a historical controversy and its enduring influence. Am J Public Health. 2002;92(5):725-9.
12. Stamler J. Lifestyles, major risk factors, proof, and public policy. Circulation. 1978;58(1):15.
13. Gillum RF, Blackburn H, Feinleib M. Current strategies for explaining the decline in ischemic heart disease mortality. J Chronic Dis. 1982; 35(6):467.
14. Beaglehole R, LaRosa JC, Heiss G, Davis CE, Williams OD, Tyroler HA, et al. Serum cholesterol, diet, and the decline in coronary heart disease mortality. Prev Med. 1979;8(5): 538-47.
15. Grover SA. Role of WHO-MONICA Project in unravelling of the cardiovascular puzzle. Lancet. 2000; 355(9205):668-9.
16. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101(6):825-36.
17. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987; 77(11):1417-26.
18. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997;277(7): 535-42.
19. Unal B, Capewell S, Critchley JA. Coronary heart disease policy models: a systematic review. BMC Public Health. 2006;6:213.
20. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
21. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999;81(4):380-6.
22. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109(9):1101-7.
23. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356(23):2388-98.
24. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005; 162(8):764-73.
25. Buchan I, Ainsworth J, Carruthers E, Couch P, O'Flaherty M, Smith D, et al. IMPACT: a generalisable system for simulating public health interventions. Stud Health Technol Inform. 2010;160 (Pt.1):486.
26. Ford ES, Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health. 2011;32:5-22.
27. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007; 50(22):2131.
28. Archimedes: quantifying healthcare [home page on the Internet]. San Francisco (CA): Archimedes; 2012 [cited 2012 May 15]. Available from: http://archimedesmodel.com/
29. Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Diabetes Care. 2008;31(8):1686-96.
30. Herman WH. Diabetes modeling. Diabetes Care. 2003;26(11):3182-3.
31. Eddy DM. Accuracy versus transparency in pharmacoeconomic modelling: finding the right balance. Pharmacoeconomics. 2006;24(9): 837-44.
32. Capewell S, Hayes DK, Ford ES, Critchley JA, Croft JB, Greenlund KJ, et al. Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000. Am J Epidemiol. 2009;170(2):229-36.
33. Unal B, Critchley JA, Fidan D, Capewell S. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health. 2005;95(1): 103-8.
34. Gouda HN, Critchley J, Powles J, Capewell S. Why choice of metric matters in public health analyses: a case study of the attribution of credit for the decline in coronary heart disease mortality in the US and other populations. BMC Public Health. 2012;12:88.
35. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Supplementary appendix in: Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23): 2388-98.
36. Marmot MG. Life style and national and international trends in coronary heart disease mortality. Postgrad Med J. 1984;60(699):8.
37. Kabir Z. Decrease in U.S. deaths from coronary disease. N Engl J Med. 2007;357(9):941.
38. Taylor-Robinson DC, Capewell S. (Authors' response to Kabir). Decrease in U.S. deaths from coronary disease. N Engl J Med. 2007; 357(9): 941.
39. Marmot MG, Rose G, Shipley M, Hamilton PJ. Employment grade and coronary heart disease in British civil servants. J Epidemiol Community Health. 1978;32(4):244-9.
40. Marmot MG. The status syndrome: how social standing affects our health and longevity. New York (NY): Times Books; 2004.
41. Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50" myth. Arch Inter Med. 2001;161(22):2657-60.
42. Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010;303(12): 1159-66.
43. Brandt AM, Gardner M. Antagonism and accommodation: interpreting the relationship between public health and medicine in the United States during the 20th century. Am J Public Health. 2000;90(5):707-15.
44. Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ. 2010;88(2):120-30.
45. Orton L, Lloyd-Williams F, Taylor-Robinson D, O'Flaherty M, Capewell S. The use of research evidence in public health decision making processes: systematic review. PLoS One. 2011;6(7):e21704